U.S. doctors call for remdesivir data to guide coronavirus treatment
May 21, 2020 at 17:08 PM EDT
U.S. doctors and others in the scientific community are calling for the release of data that convinced health regulators to authorize emergency use of Gilead Sciences Inc's antiviral drug remdesivir to treat COVID-19, so they can direct limited supplies on the right patients.
